Efficacy and Safety of Pembrolizumab in Patients With Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response

Cancer Research and Treatment - South Korea
doi 10.4143/crt.2019.493

Related search